Gilboa David Abraham reported option exercise involving 75,402 derivative units of Warby Parker Inc. at $0.00 for $0 on Nov 9, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Co-Chief Executive Officer
Co-Chief Executive Officer
Filed Nov 12, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
75,402Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
463,789Direct
Trade date
Nov 9, 2026Option exercise
Filed
Nov 12, 2026, 7:06 PM ET4-day reporting delay
Accession
0001883353-26-000010Code M · Transaction 399929
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Option exercise75,402$3.83$288,789.66Trade 399930
Nov 9, 2026Conversion75,402$0.00$0Trade 399931
Nov 9, 2026Sell75,402$29.82−$2,248,487.64Trade 399928
Nov 9, 2026Conversion75,402$0.00$0Trade 399927
5 transaction rows in this filing. Joint filers share the same rows.

WRBY price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
WRBY · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −5.3%1w ago −7.9%1d ago −4.7%
Returns since7d30d90d180d1y

Footnotes in full

F1: These share sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2026. F2: The price reported in Column 4 is an average execution price rounded to the nearest hundredth. These shares were sold in multiple transactions at prices ranging from $29.75 to $29.94 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3: The Stock option was granted on February 22, 2017, is fully vested, and will expire on February 21, 2027. F4: The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis. The Class B Common Stock will automatically convert into shares of the Issuer's Class A Common Stock on a one-to-one basis upon the earlier of (i) transfer of Class B Common Stock to a person or entity that is not in the transferor's permitted ownership group, (ii) October 1, 2031, (iii) with respect to any Class B Common Stock held by any person or entity in Neil Blumenthal's permitted ownership group, (A) such time as Neil Blumenthal is removed or resigns from the board of directors, or otherwise ceases to serve as a director, (B) such time as Neil Blumenthal ceases to be either an employee, officer or consultant of the Company or any of its subsidiaries, or (C) the date that is 12 months after the death or disability of Neil Blumenthal, F5: and (iv) with respect to any Class B common stock held by any person or entity in Dave Gilboa's permitted ownership group, (A) such time as Dave Gilboa is removed or resigns from the board of directors, or otherwise ceases to serve as a director, (B) such time as Dave Gilboa ceases to be either an employee, officer or consultant of the Company or any of its subsidiaries, or (C) the date that is 12 months after the death or disability of Dave Gilboa.